TLRY
Tilray Brands, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.03
−0.33%Margins
Gross margin
28.5%
EBITDA margin
-1.9%
EBIT margin
-8.0%
Net margin
-17.1%
FCF margin
-13.2%
-10.1%
Return on equity
-7.1%
Return on assets
-3.9%
Return on invested capital
0.41x
Asset turnover
-$88.1M
Cash from operations
$1.48
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Aug 1, 2026